Skip to main content
. Author manuscript; available in PMC: 2016 Nov 1.
Published in final edited form as: Health Secur. 2015 Nov-Dec;13(6):365–377. doi: 10.1089/hs.2015.0032

Table 3.

Antitoxin Treatment in Human Inhalation Anthrax

Case Age Gender Exposure Clinical Presentation Antimicrobial Initiation Post Symptom Onset (Days) Antimicrobial Treatment Additional Supportive Care Anthrasil Administration Post Symptom Onset (Days) Outcome
44, 47 44 M Animal hide drums Dyspnea, cough, syncope, chest pain, bilateral pleural effusions, mediastinal fluid, progressive respiratory failure, elevated liver enzymes, elevated creatinine 2–3 Ceftriaxone, azithromycin, moxifloxacin, clindamycin, piperacillin/tazobactam Mechanical ventilation, pleural fluid drainage, vasopressors 9 Lived
45, 46 61 M Unknown, presumed environmental Fever, productive cough, exertional dyspnea, progressive respiratory failure, elevated creatinine 2 Ceftriaxone, azithromycin, ciprofloxacin, meropenem, vancomycin, rifampin, clindamycin Mechanical ventilation, pleural fluid drainage 7 Lived
42, 43 34 M Animal hide drums Fever, night sweats, rigors, rapid respiratory failure, pleural effusions, widened mediastinum, multi-organ failure 2 Amoxicillin, clarithromycin, piperacillin/tazobactam, rifampicin, ciprofloxacin, clindamycin Multi-organ support: mechanical ventilation, pleural fluid drainage, vasopressors, steroids 8 Died